Skip to main content

Multisystem Atrophy (MSA)

  • Reference work entry
  • First Online:
Geriatric Diseases

Abstract

MSA can cause combinations of Parkinsonism, autonomic, pyramidal and cerebellar symptoms. MSA-A is now the term used for Shy-Drager syndrome, MSA-C if cerebellar symptoms predominate and MSA-P if Parkinsonian features predominate. The aetiology is uncertain although recently it has been attributed to a human prion composed of the alpha-synuclein protein. This chapter gives a concise account of the demographic, clinical characteristics and management of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 379.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hain TC. Multiple System Atrophy (MSA),. http://www.dizziness-and-balance.com/disorders/central/movement/msa.html accessed on 10 May 2016.

  2. Ben-ShlomoY, Wening GK, Tison F, Quinn NP. Survival of patients with pathologically proven multiple system atrophy. A meta analysis. Neurology. 1997;48:384–39.

    Google Scholar 

  3. Best C. MSA Management strategies. EPNN Journal Winter 2007.

    Google Scholar 

  4. Quinn NP, Marsden CD. The motor disorder of multiple system atrophy/ Editorial. J Neurol Neurosurg Psychiatry. 1993;56 1239–1242.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Papapetropoulos S, Thchman A, Laufer D, Papatsoris AG, Papapetropoulos N, Mash DC. Causes of death in multisystem atrophy. J Neurol Neurosurg Psychiatry. 2006; 78(2):327–329.

    Article  Google Scholar 

  6. Tada M, Onodera O, Tada M, Ozawa T, PiaoY, Kakita A, et al. Early development of autonomic dysfunction predict poor prognosis in patients with multisystem atrophy. Arch Neurol. 2007;64(2):256.

    Article  PubMed  Google Scholar 

  7. Watanabe H, Saito Y, Terao S, Ando T, Kachi T, Mukai E, et al. Progression and prognosis in Multisystem atrophy: an analysis of 230 Japanese patients. Brain. 2002;125(Pt 5):1070.

    Article  PubMed  Google Scholar 

  8. Lee PH, Kim JW, Bang OY, Ahn YH, Joo IS, HuhK. Autologous mesenchymal stem cell therapy delay the progression of neurological deficits. Clin Pharmacol Therapeutics. 2000;83:723–730.

    Article  Google Scholar 

  9. Stefanova N, Bucke P, Duerr S, Wenng GK. Multiple system atrophy: an update .Lancet Neurol. 2009;8(12):1172–8.

    Article  CAS  PubMed  Google Scholar 

  10. Goldstein DS, Holme S, Li ST, Bruce S, Metman LV.Cannon RO 3rd. Cardiac sympathetic denervation in Parkinson’s disease. Ann Intern Med. 2000;133:338–347.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Nagaratnam, N., Nagaratnam, K., Cheuk, G. (2018). Multisystem Atrophy (MSA). In: Geriatric Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-33434-9_41

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-33434-9_41

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-33433-2

  • Online ISBN: 978-3-319-33434-9

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics